MERCK Kommanditgesellschaft auf Akt... (MRK.DE)

169.2 €

-1.20 (-0.70%)
Symbol MRK.DE
Price 169.2 €
Beta 0.644
Volume Avg. 0.29M
Market Cap 73.564B
Shares () -
52 Week Range 153.1-202.8
1y Target Est -
DCF Unlevered MRK.DE DCF ->
DCF Levered MRK.DE LDCF ->
ROE 12.90% Buy
ROA 6.85% Neutral
Operating Margin -
Debt / Equity 86.86% Buy
P/E 21.61 Strong Buy
P/B 2.84 Strong Buy


Consensus EPS

Upgrades & Downgrades

Ms. Belen Garijo Lopez M.D.
Drug Manufacturers—Specialty & Generic
Frankfurt Stock Exchange

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.